Ovarian Neoplasms: all 2,757 studies
Page 12 of 28. Open to participants first (735), then studies with results posted, then the rest; newest registration first within each.
- Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid TumorTerminatedNCT00523809Phase 2Results posted
- Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian CancerCompletedNCT00511992Phase 2Results posted
- Gleevec Study for Patients With Ovarian CancerCompletedNCT00510653Phase 2Results posted
- Letrozole in Patients With Ovarian TumorsTerminatedNCT00505661Phase 2Results posted
- Chemoimmunotherapy Study for Patients With Epithelial Ovarian CancerCompletedNCT00501644Phase 2Results posted
- Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian CancerCompletedNCT00494442Phase 2Results posted
- Trial of Decitabine as a Sensitizer to Carboplatin in Platinum Resistant Recurrent Ovarian CancerCompletedNCT00477386Phase 1/2Results posted
- Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell TumorsCompletedNCT00467051Phase 2Results posted
- Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian CancerCompletedNCT00445887Phase 2Results posted
- Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal CancerTerminatedNCT00445549Phase 2Results posted
- Safety and Efficacy Study of Glufosfamide in Ovarian CancerTerminatedNCT00442598Phase 2Results posted
- Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal CancerCompletedNCT00436215Phase 2Results posted
- A Study of Chemotherapy Treatment for Patients With Ovarian CancerCompletedNCT00428610Phase 2Results posted
- A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse TreatmentCompletedNCT00421889Phase 1/2Results posted
- Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer PatientsTerminatedNCT00418574Phase 2/3Results posted
- Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian CancerCompletedNCT00408603Phase 2Results posted
- Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00408590Phase 1Results posted
- Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal CancerTerminatedNCT00408070Phase 2Results posted
- AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant AscitesCompletedNCT00396591Phase 2Results posted
- Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")CompletedNCT00391118Phase 2Results posted
- Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian CancerCompletedNCT00390611Phase 2Results posted
- Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)CompletedNCT00390182Phase 1/2Results posted
- Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to ChemotherapyCompletedNCT00377429Phase 2Results posted
- Vaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerTerminatedNCT00373217Phase 2Results posted
- Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian CancerCompletedNCT00345540Phase 2Results posted
- Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn CancersCompletedNCT00343044Phase 2Results posted
- Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant AscitesCompletedNCT00327444Phase 2/3Results posted
- Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian CancerCompletedNCT00327171Phase 2Results posted
- Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical CancersCompletedNCT00319748Phase 2Results posted
- Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based ChemotherapyCompletedNCT00318370Phase 2Results posted
- Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube CancerCompletedNCT00317772Phase 1/2Results posted
- Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian CancerCompletedNCT00316173Phase 2Results posted
- Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential TumorsCompletedNCT00301756Phase 2Results posted
- Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative MedicineCompletedNCT00293293Not applicableResults posted
- A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian CancerCompletedNCT00281632Phase 2Results posted
- Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal CancerCompletedNCT00267696Phase 2Results posted
- Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00262847Phase 3Results posted
- Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving TrastuzumabCompletedNCT00194714Phase 1/2Results posted
- An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior ChemotherapyCompletedNCT00191646Phase 3Results posted
- Gemcitabine in Ovarian CancerCompletedNCT00191334Phase 2Results posted
- Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian CancerCompletedNCT00170625Phase 1/2Results posted
- Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian CancerCompletedNCT00170573Phase 2Results posted
- Taxol Carboplatin and ErythropoetinCompletedNCT00158379Phase 2Results posted
- GM-CSF, Sargramostim in Women With Recurrent Ovarian CancerCompletedNCT00157573Phase 2Results posted
- Bevacizumab and Erlotinib Study in Advanced Ovarian CancerCompletedNCT00130520Phase 2Results posted
- Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)CompletedNCT00129727Phase 2Results posted
- An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian CancerCompletedNCT00113607Phase 3Results posted
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube CancerStatus unknownNCT00108745Phase 3Results posted
- Second-Line Treatment for Patients With Platinum-Sensitive Ovarian CancerCompletedNCT00090610Phase 2Results posted
- Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00072566Phase 2Results posted
- Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial CancerCompletedNCT00072410Phase 1Results posted
- Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical CancerCompletedNCT00069160Phase 2Results posted
- A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian CancerCompletedNCT00058552Phase 2Results posted
- Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell TumorsCompletedNCT00053352Phase 3Results posted
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00011986Phase 3Results posted
- S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian CancerCompletedNCT00008138Phase 2Results posted
- Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian CancerTerminatedNCT00006099Phase 1Results posted
- S9912 Combination Chemo in Stage III Ovarian Cancer,CompletedNCT00003896Phase 2Results posted
- Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian CancerCompletedNCT00003644Phase 3Results posted
- Circulating Endothelial Cells (CECs) as Potential Predictive/Prognostic Biomarkers in Ovarian CancerCompletedNCT07807683
- Longitudinal Plasma Proteomic Remodeling in Ovarian CancerCompletedNCT07684846Not applicable
- The Use of Artificial Intelligence for Ultrasound Screening of Ovarian Cancer in Postmenopausal WomenActive, not recruitingNCT07660718
- The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant TumorsCompletedNCT07651020
- Does Cediranib Prevent Bowel Perforation in Platinum-resistant Ovarian CancerCompletedNCT07648745Phase 2
- Safety of Opportunistic Salpingectomy During Elective Laparoscopic Cholecystectomy.Active, not recruitingNCT07642791Not applicable
- Validation of ESGO Quality Indicators in Advanced Ovarian Cancer SurgeryCompletedNCT07567573
- An Integrated Genomic Approach to Assess Genetic Risk and Drug SensitivityActive, not recruitingNCT07555639Not applicable
- ASTRA Study: Circulating Tumor Cells in Blood of Patients With High-Grade Serous Ovarian CancerCompletedNCT07439328Not applicable
- Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or ImmunotherapyCompletedNCT07393633
- Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer SurvivorsActive, not recruitingNCT07259304
- Virtual Mental Health Intervention to Address Fear of Progression for Women With High Risk or Stage III-IV Gynecologic or Breast CancerWithdrawnNCT07226102Not applicable
- Additive Role of ADC Value to ORADS in Adnexal LesionsCompletedNCT07202429
- A Controlled Clinical Trial Assessing the Efficacy of Vitamin B Prophylaxis in Attenuating Paclitaxel-induced Neuropathy and the Imperative Use of Gabapentin in Diabetic Ovarian Cancer Patients and the Potential Effect on Disease Response.CompletedNCT07191587Not applicable
- CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid TumorsSuspendedNCT07181720Phase 1
- Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of HistologyActive, not recruitingNCT07167433
- Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel ChemotherapyCompletedNCT07154966
- AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncerWithdrawnNCT07146919Phase 1/2
- Hugo™ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)Active, not recruitingNCT07120945Not applicable
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersActive, not recruitingNCT07118176Phase 1
- Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1)Active, not recruitingNCT07109414Phase 2/3
- Glove Compression for Chemotherapy-Induced NeuropathyCompletedNCT07105553Not applicable
- An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian CancerActive, not recruitingNCT07096583Phase 1/2
- A Master Protocol Study to Investigate Biomarker-guided Novel Anticancer Agent(s) as Monotherapy or Combination Therapy in Participants With Advanced/Recurrent Ovarian CancerWithdrawnNCT07060365Phase 1/2
- A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsActive, not recruitingNCT07038369Phase 1
- Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in CanadaTerminatedNCT07035067
- A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationActive, not recruitingNCT07023731Phase 1/2
- O-RADS MRI System on Early Detection of Ovarian CancerActive, not recruitingNCT07009743
- A Study of Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP InhibitorTerminatedNCT07000344Not applicable
- IOTA Ultrasound Criteria and Serum CA 125 for Ovarian Malignancy DetectionCompletedNCT06977334
- ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid TumorsCompletedNCT06973161
- NGS-based Germline and Somatic Genetic Test in Ovarian CarcinomaActive, not recruitingNCT06972693Phase 4
- Sexual Health Integration in Treatment of Gynecological OncologyCompletedNCT06958068
- SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal MetastasesActive, not recruitingNCT06940921Phase 1/2
- A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in TaiwanCompletedNCT06925113
- Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTOCompletedNCT06917469
- A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian CancerActive, not recruitingNCT06888921Phase 1/2
- METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced Epithelial Ovarian CancerActive, not recruitingNCT06884345Phase 1/2
- Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer SurgeryCompletedNCT06879353Not applicable
- Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer TreatmentCompletedNCT06870539
- Regional Distribution Mapping of Lymph Node Metastasis in Epithelial Ovarian CancerCompletedNCT06853730